Affiance Financial LLC reduced its position in shares of Procter & Gamble Co (NYSE:PG) by 3.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,840 shares of the company’s stock after selling 150 shares during the period. Affiance Financial LLC’s holdings in Procter & Gamble were worth $421,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PG. First Hawaiian Bank increased its position in shares of Procter & Gamble by 41.6% in the fourth quarter. First Hawaiian Bank now owns 33,809 shares of the company’s stock worth $3,107,000 after purchasing an additional 9,934 shares during the last quarter. Abner Herrman & Brock LLC boosted its stake in Procter & Gamble by 7.9% in the fourth quarter. Abner Herrman & Brock LLC now owns 14,639 shares of the company’s stock worth $1,346,000 after buying an additional 1,073 shares in the last quarter. Visionary Asset Management Inc. purchased a new stake in Procter & Gamble in the fourth quarter worth approximately $294,000. Global Trust Asset Management LLC boosted its stake in Procter & Gamble by 45.2% in the fourth quarter. Global Trust Asset Management LLC now owns 4,477 shares of the company’s stock worth $412,000 after buying an additional 1,393 shares in the last quarter. Finally, First American Trust FSB boosted its stake in Procter & Gamble by 4.6% in the fourth quarter. First American Trust FSB now owns 81,994 shares of the company’s stock worth $7,537,000 after buying an additional 3,637 shares in the last quarter. Institutional investors and hedge funds own 62.20% of the company’s stock.

PG traded down $1.45 on Tuesday, hitting $113.85. 6,194,202 shares of the company’s stock traded hands, compared to its average volume of 8,037,966. The firm has a 50 day simple moving average of $111.83. The company has a market capitalization of $288.48 billion, a price-to-earnings ratio of 26.98, a price-to-earnings-growth ratio of 3.50 and a beta of 0.45. Procter & Gamble Co has a one year low of $77.54 and a one year high of $116.52. The company has a current ratio of 0.79, a quick ratio of 0.60 and a debt-to-equity ratio of 0.39.

Procter & Gamble (NYSE:PG) last issued its earnings results on Tuesday, April 23rd. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.02. The company had revenue of $16.46 billion for the quarter, compared to the consensus estimate of $16.37 billion. Procter & Gamble had a return on equity of 21.61% and a net margin of 16.44%. The firm’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter last year, the company earned $1.00 EPS. Equities analysts predict that Procter & Gamble Co will post 4.48 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $0.7459 per share. This represents a $2.98 annualized dividend and a yield of 2.62%. The ex-dividend date is Thursday, July 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 70.62%.

In related news, insider Deborah P. Majoras sold 6,161 shares of Procter & Gamble stock in a transaction that occurred on Thursday, April 25th. The stock was sold at an average price of $103.10, for a total transaction of $635,199.10. Following the sale, the insider now owns 44,996 shares of the company’s stock, valued at approximately $4,639,087.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David S. Taylor sold 30,000 shares of Procter & Gamble stock in a transaction that occurred on Friday, April 26th. The stock was sold at an average price of $105.00, for a total value of $3,150,000.00. Following the completion of the sale, the chief executive officer now directly owns 256,088 shares in the company, valued at approximately $26,889,240. The disclosure for this sale can be found here. Insiders have sold a total of 320,840 shares of company stock worth $33,904,086 in the last three months. 1.84% of the stock is owned by corporate insiders.

A number of analysts have recently weighed in on the company. Scotiabank reissued a “buy” rating on shares of Procter & Gamble in a research note on Friday, July 5th. Goldman Sachs Group raised to a “neutral” rating and dropped their price target for the stock from GBX 1,855 ($24.24) to GBX 1,800 ($23.52) in a research note on Thursday, June 27th. UBS Group increased their price objective on W. R. Berkley from $53.00 to $56.00 and gave the stock a “sell” rating in a report on Wednesday, April 24th. Morgan Stanley set a $111.00 price objective on Procter & Gamble and gave the stock a “buy” rating in a report on Thursday, March 28th. Finally, Deutsche Bank reiterated a “buy” rating and issued a GBX 430 ($5.62) price objective on shares of in a report on Monday, June 17th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. Procter & Gamble has an average rating of “Hold” and an average price target of $102.32.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Read More: Is it Safe to Invest in Commodities?

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.